Status:
TERMINATED
Response to Relapse in Office-Based Opioid Treatment Trial
Lead Sponsor:
Boston Medical Center
Collaborating Sponsors:
Substance Abuse and Mental Health Services Administration (SAMHSA)
Conditions:
Opioid-use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In a sample of individuals with co-occurring OUD and mental disorders, the investigators plan to test two medications for opioid use disorder (MOUD) treatment protocols that involve differing approach...
Detailed Description
This study is a single-center, two-arm, 6-month (24-week), parallel group, open-label, randomized controlled trial to examine the effectiveness of two approaches to managing relapse to illicit drug us...
Eligibility Criteria
Inclusion
- Opioid use disorder \[based on Diagnostic Statistical Manual 5 (DSM5) criteria assessed by clinician interview\]
- Mental disorder (based on DSM5 criteria assessed by clinician interview)
- Willingness to receive treatment with office-based medication for opioid use disorder
- Willingness to name at least 1 contact for follow up purposes
- Enrollment in the ABOVE program
Exclusion
- Pregnancy (urine testing if childbearing potential) or breast feeding
- Suicidal or homicidal ideation that requires immediate attention
- Cognitive dysfunction that precludes informed consent or research staff assessment that participant cannot understand interview questions
Key Trial Info
Start Date :
February 7 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 12 2020
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT03812107
Start Date
February 7 2019
End Date
March 12 2020
Last Update
January 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Medical Center
Boston, Massachusetts, United States, 02118